Overview

Update
Primary Role
Board Of Directors @
Investments
21 Investments in 10 Companies
Gender:
Male
Location:
Boston
Social:

Person Details

Update

Kevin is the interim president of Editas Medicine and a principal at Polaris Partners. He joined Polaris in 2004 and focuses on investments in health care. Kevin is a co-founder of Genocea Biosciences and Sirtris Pharmaceuticals (acquired by GSK) and was the founding CEO at Visterra Inc. (formerly Parasol Therapeutics).

He currently represents Polaris as a director of InSeal Medical, Genocea Biosciences, Kala Pharmaceuticals, Neuronetics, Inc., Visterra Inc., Taris Biomedical and Vets First Choice. Additionally, he is a board observer to Arsenal Medical and 480 Biomedical.Kevin holds a Ph.D. in genetics from Harvard Medical School. His doctoral research focused on the molecular regulation of caloric restriction and on modulation of a novel class of protein deacetylases.

Jobs (11)

Update
Current

Director

Interim President

Director

Partner

Jul, 2004 - Current   (about 12 years)
Past
Started
Ended
Title
Company
Unknown
Unknown
Co - Founder
Unknown
Unknown
CEO
Unknown
Unknown
Founding CEO
Unknown
Unknown
Director
2006
Unknown
Co - Founder

Education (2)

Update

Add Memberships

Add Images

Add Videos